Sign in

CIK 0001851484 · <br>Emerging growth company

CITIUS ONCOLOGY, INC.

Sign in to watch
Ticker
CTOR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Sep 30
Incorporated
DE
Entity type
operating
EIN
994362660
Phone
(908) 967-6677
Business address
11 COMMERCE DRIVE, 1ST FLOOR, CRANFORD, NJ, 07016
Former names
TenX Keane Acquisition
  1. DEF 14C Other DEF 14C
  2. PRE 14C Other PRE 14C
  3. EFFECT Other Notice of Effectiveness
  4. CORRESP Other Correspondence Between Filers and SEC Staff
  5. UPLOAD Other SEC-generated Letter
  6. S-3 Offering Registration Statement
  7. 8-K Event Results of operations
  8. 10-K Report Annual Report
  9. 4/A Grant or award Director acquired 300,000 shares (grant or award)
  10. 4/A Grant or award Secretary acquired 850,000 shares (grant or award)
  11. 4/A Grant or award Chief Medical Officer acquired 825,000 shares (grant or award)
  12. 4/A Grant or award Chief Financial Officer acquired 825,000 shares (grant or award)
  13. 4/A Grant or award Chief Executive Officer acquired 1,700,000 shares (grant or award)
  14. 4/A Grant or award Director acquired 300,000 shares (grant or award)
  15. 4/A Grant or award Director acquired 300,000 shares (grant or award)
  16. 4/A Grant or award Director acquired 300,000 shares (grant or award)
  17. 4/A Grant or award Director acquired 300,000 shares (grant or award)
  18. 4/A Grant or award Director acquired 300,000 shares (grant or award)
  19. SCHEDULE 13D/A Stake Beneficial Ownership Report
  20. 8-K Event Material agreement · Unregistered share sale · Other events

Page 3 of 14 · 268 filings